Observational studyBMJ open respiratory research2022

Clinical utility of anti-interleukin 5 monoclonal therapy in asthma using a national, centralised, outcome-based system of drug access.

Caroline O'Leary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.